Association of interleukin-10 promoter genetic variants with T-cell and B-cell activation in HIV-1 infection

被引：0
|
作者：
Naicker, D. [1 ]
Julg, B. [2 ]
McClurg, C. [2 ]
Ghebremichael, M. [2 ]
Porichis, F. [2 ]
Zupkosky, J. [2 ]
Jaggernath, M. [1 ]
Mokgoro, M. [1 ]
Goulder, P. [3 ]
Walker, B. [2 ]
Kaufmann, D. [2 ]
Ndung'u, T. [1 ]
机构：
[1] HIV Pathogenesis Programme, Durban, South Africa
[2] Ragon Inst MGH MIT & Harvard, Boston, MA USA
[3] Univ Oxford, Dept Paediat, Oxford OX1 2JD, England
来源：
RETROVIROLOGY | 2012年 / 9卷
关键词：
Promoter Polymorphism; Allelic Discrimination; Immunoregulatory Cytokine; TaqMan Allelic Discrimination; Antibody Combination;
D O I：
10.1186/1742-4690-9-S2-P168
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] VIRAL SUPERANTIGEN-INDUCED HYPORESPONSIVENESS OF T-CELLS AND POLYCLONAL B-CELL ACTIVATION IN HIV-1 INFECTION
    SCOTTALGARA, D
    LAFON, M
    VUILLIER, F
    PIALOUX, G
    DAUGUET, C
    DIGHIERO, G
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (11) : 2595 - 2601
  • [42] Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection
    Scott, MJ
    Hoth, JJ
    Turina, M
    Woods, DR
    Cheadle, WG
    CYTOKINE, 2006, 33 (02) : 79 - 86
  • [43] B-cell epitopes in HIV-1 Tat and Rev proteins colocalize with T-cell epitopes and with functional domains
    Tähtinen, M
    Ranki, A
    Valle, SL
    Ovod, V
    Krohn, K
    BIOMEDICINE & PHARMACOTHERAPY, 1997, 51 (10) : 480 - 487
  • [44] Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma
    Lech-Maranda, E
    Baseggio, L
    Bienvenu, J
    Charlot, C
    Berger, F
    Rigal, D
    Warzocha, K
    Coiffier, B
    Salles, G
    BLOOD, 2004, 103 (09) : 3529 - 3534
  • [45] Regulatory T cell frequencies correlate with T cell activation in chronic HIV-1 infection
    Angin, M.
    Streeck, H.
    Wen, F.
    Pyo, A.
    Trocha, A.
    Toth, I.
    Kwon, D.
    Pereyra, F.
    Alter, G.
    Altfeld, M.
    Walker, B. D.
    Addo, M. M.
    RETROVIROLOGY, 2009, 6
  • [46] Linear fusion of HIV-1 B- and heterologous T-cell epitopes. I. Antigenic properties of HIV-1 B-cell epitope are preserved
    Inst Virusologii im. D.I., Ivanovskogo RAMN, Moscow, Russia
    Biokhimiya, 7 (1221-1229):
  • [47] Effective B cell activation in vitro during viremic HIV-1 infection with surrogate T cell stimulation
    Nicholson, Lindsay K.
    Pratap, Harsh
    Bowers, Elisabeth
    Gunzburger, Elise
    Bandi, Srinivasa R.
    Gardner, Edward M.
    Palmer, Brent E.
    Wright, Timothy
    Kittelson, John
    Janoff, Edward N.
    IMMUNOBIOLOGY, 2018, 223 (12) : 839 - 849
  • [48] Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis
    Guedez, L
    Mansoor, A
    Birkedal-Hansen, B
    Lim, MS
    Fukushima, P
    Venzon, D
    Stetler-Stevenson, WG
    Stetler-Stevenson, M
    BLOOD, 2001, 97 (06) : 1796 - 1802
  • [49] B-cell subset alterations and correlated factors in HIV-1 infection
    Pensieroso, Simone
    Galli, Laura
    Nozza, Silvia
    Ruffin, Nicolas
    Castagna, Antonella
    Tambussi, Giuseppe
    Hejdeman, Bo
    Misciagna, Donatella
    Riva, Agostino
    Malnati, Mauro
    Chiodi, Francesca
    Scarlatti, Gabriella
    AIDS, 2013, 27 (08) : 1209 - 1217
  • [50] INTERLEUKIN-1 AND T-CELL ACTIVATION
    MIZEL, SB
    IMMUNOLOGY TODAY, 1987, 8 (11): : 330 - 332
12345